l-Lysergide

• CAT Number: I030908
• CAS Number: 3184-49-4
• Molecular Formula: C20H25N3O
• Molecular Weight: 323.44
• Purity: 98%
• Synonyms: l-Lysergide; l-LSD; (-)-Lysergic acid diethylamide
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: (6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
• InChI: InChI=1S/C20H25N3O/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14/h6-9,11,14,18,21H,4-5,10,12H2,1-3H3/t14-,18-/m1/s1
• InChIKey: VAYOSLLFUXYJDT-RDTXWAMCSA-N
• SMILES: [H][C@@]1(N(C[C@@H](C=C12)C(N(CC)CC)=O)C)CC3=CNC4=C3C2=CC=C4

Lysergide (LSD)(Cat No.: I030908) is a potent semisynthetic psychedelic compound derived from lysergic acid, found in ergot fungus. Known for its profound effects on perception, emotions, and consciousness, LSD influences serotonin receptor pathways, often causing visual hallucinations, synesthesia, and altered states of awareness. Developed by Albert Hofmann in 1938, LSD gained popularity in the 1960s counterculture movement. Its potential therapeutic use has been re-explored in modern clinical research. However, it remains a controlled substance in many countries due to significant abuse potential.

Reference

1: Himmelsbach M, Ferdig M, Rohrer T. Analysis of paspalic acid, lysergic acid, and iso-lysergic acid by capillary zone electrophoresis with UV- and quadrupole time-of-flight mass spectrometric detection. Electrophoresis. 2014 May;35(9):1329-33. doi: 10.1002/elps.201300224. Epub 2013 Oct 18. PubMed PMID: 24115177.
2: Merli D, Zamboni D, Protti S, Pesavento M, Profumo A. Electrochemistry and analytical determination of lysergic acid diethylamide (LSD) via adsorptive stripping voltammetry. Talanta. 2014 Dec;130:456-61. doi: 10.1016/j.talanta.2014.07.037. Epub 2014 Jul 22. PubMed PMID: 25159435.
3: GIBERTI F, GREGORETTI. [Comparative study of the psychopathological effects of lysergic acid ethylamide, (L. A. E. 32) & lysergic acid diethylamide, (L. S. D. 25) in neurotics]. Sist Nerv. 1958 Mar-Apr;10(2):97-110. Italian. PubMed PMID: 13580425.
4: Sarsúnová M, Semonský M, Cerný A. Ergot alkaloids. XXXVI. Separation of diastereomeric (+)-1-hydroxy-2-butylamides of D- and L-lysergic and D- and L-isolysergic acids by thin-layer chromatography. J Chromatogr. 1970 Aug 12;50(3):442-6. PubMed PMID: 5449459.
5: HOFMANN A, TSCHERTER H. [Isolation of lysergic acid alkaloids from the Mexican drug ololiuqui (Rivea corymbosa (L.) Hall.f.)]. Experientia. 1960 Sep 15;16:414. German. PubMed PMID: 13715089.
6: Inuki S, Iwata A, Oishi S, Fujii N, Ohno H. Enantioselective total synthesis of (+)-lysergic acid, (+)-lysergol, and (+)-isolysergol by palladium-catalyzed domino cyclization of allenes bearing amino and bromoindolyl groups. J Org Chem. 2011 Apr 1;76(7):2072-83. doi: 10.1021/jo102388e. Epub 2011 Mar 1. PubMed PMID: 21361331.
7: Keller U, Han M, Stöffler-Meilicke M. D-lysergic acid activation and cell-free synthesis of D-lysergyl peptides in enzyme fractions from the ergot fungus Claviceps purpurea. Biochemistry. 1988 Aug 9;27(16):6164-70. PubMed PMID: 2847788.
8: Sietnieks A. Involvement of 5-HT2 receptors in the LSD- and L-5-HTP-induced suppression of lordotic behavior in the female rat. J Neural Transm. 1985;61(1-2):65-80. PubMed PMID: 3872342.
9: Winkelhake JL, Voss EW Jr, Lopatin DE. Comparative inhibitory action of D- and L-tryptophan on the effect of d-lysergic acid diethylamide in vitro. Mol Pharmacol. 1974 Jan;10(1):68-77. PubMed PMID: 4136154.
10: Truhaut R, Deysson G. [Absence of lysergic diethylamide effect on the chromosomes in Allium sativum L. meristematic radicular cells]. C R Acad Sci Hebd Seances Acad Sci D. 1970 Feb 23;270(8):1165-6. French. PubMed PMID: 4985239.
11: Mendoza A, López de Alda M, González-Alonso S, Mastroianni N, Barceló D, Valcárcel Y. Occurrence of drugs of abuse and benzodiazepines in river waters from the Madrid Region (Central Spain). Chemosphere. 2014 Jan;95:247-55. doi: 10.1016/j.chemosphere.2013.08.085. Epub 2013 Sep 29. PubMed PMID: 24083902.
12: Sietnieks A, Meyerson BJ. Progesterone enhancement of lysergic acid diethylamide and levo-5-hydroxytryptophan stimulation of the copulatory response in the female rat. Neuroendocrinology. 1983 Jun;36(6):462-7. PubMed PMID: 6603590.
13: Yamamoto T, Walker EA, Woods JH. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan. J Pharmacol Exp Ther. 1991 Sep;258(3):999-1007. PubMed PMID: 1890629.
14: Hungen KV, Roberts S, Hill DF. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain. Brain Res. 1975 Aug 22;94(1):57-66. PubMed PMID: 238721.
15: Nichols DE. Hallucinogens. Pharmacol Ther. 2004 Feb;101(2):131-81. Review. PubMed PMID: 14761703.
16: Kerrigan S, Brooks DE. Indirect enzyme-linked immunosorbent assay for the quantitative estimation of lysergic acid diethylamide in urine. Clin Chem. 1998 May;44(5):985-90. PubMed PMID: 9590371.
17: Abraham HD. L-5-hydroxytryptophan for LSD-induced psychosis. Am J Psychiatry. 1983 Apr;140(4):456-8. PubMed PMID: 6601463.
18: Filla A, Hiripi L, Elekes K. Serotonergic and dopaminergic influence of the duration of embryogenesis and intracapsular locomotion of Lymnaea stagnalis L. Acta Biol Hung. 2004;55(1-4):315-21. PubMed PMID: 15270248.
19: Chiu S, Mishra RK. Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy. Naunyn Schmiedebergs Arch Pharmacol. 1980 Aug;313(1):45-50. PubMed PMID: 6111027.
20: Klinke HB, Müller IB, Steffenrud S, Dahl-Sørensen R. Two cases of lysergamide intoxication by ingestion of seeds from Hawaiian Baby Woodrose. Forensic Sci Int. 2010 Apr 15;197(1-3):e1-5. doi: 10.1016/j.forsciint.2009.11.017. Epub 2009 Dec 16. PubMed PMID: 20018470.